35.56MMarket Cap-520P/E (TTM)
0.833High0.800Low40.62KVolume0.811Open0.810Pre Close33.03KTurnover0.15%Turnover RatioLossP/E (Static)42.70MShares1.76052wk High0.27P/B22.11MFloat Cap0.74052wk Low--Dividend TTM26.55MShs Float18.948Historical High--Div YieldTTM4.11%Amplitude0.740Historical Low0.813Avg Price1Lot Size
Achilles Therapeutics Stock Forum
NEWS
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Moomoo 24/7· 1 min ago
Achilles Therapeutics (ACHL.Improved VELOS manufacturing process delivering higher cNeT doses.
Protocols updated to evaluate the benefit of enhanced host conditioning, with further data expected in 2H 2024.
First three patients dosed in CHIRON and T...
Watchlist.
$ZyVersa Therapeutics(ZVSA.US)$ $Roma Green Finance(ROMA.US)$ $Veru Inc(VERU.US)$ $Achilles Therapeutics(ACHL.US)$ $Gaxos.ai(GXAI.US)$ $Applied Therapeutics(APLT.US)$ $Sonder Holdings(SOND.US)$
📊⚡️📊
No comment yet